These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 23650391)

  • 1. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.
    Mao P; Joshi K; Li J; Kim SH; Li P; Santana-Santos L; Luthra S; Chandran UR; Benos PV; Smith L; Wang M; Hu B; Cheng SY; Sobol RW; Nakano I
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8644-9. PubMed ID: 23650391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells.
    Chandran UR; Luthra S; Santana-Santos L; Mao P; Kim SH; Minata M; Li J; Benos PV; DeWang M; Hu B; Cheng SY; Nakano I; Sobol RW
    Genom Data; 2015 Sep; 5():333-336. PubMed ID: 26251826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell signature in glioblastoma: therapeutic development for a moving target.
    Nakano I
    J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.
    Sullivan KE; Rojas K; Cerione RA; Nakano I; Wilson KF
    Oncotarget; 2017 Apr; 8(14):22325-22343. PubMed ID: 28423611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells.
    Chen Z; Wang HW; Wang S; Fan L; Feng S; Cai X; Peng C; Wu X; Lu J; Chen D; Chen Y; Wu W; Lu D; Liu N; You Y; Wang H
    J Clin Invest; 2019 Apr; 129(5):2043-2055. PubMed ID: 30958800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells.
    Chen Z; Wang H; Zhang Z; Xu J; Qi Y; Xue H; Gao Z; Zhao R; Wang S; Zhang S; Qiu W; Guo X; Li G
    J Exp Clin Cancer Res; 2021 Jan; 40(1):20. PubMed ID: 33413577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells.
    Cheng P; Wang J; Waghmare I; Sartini S; Coviello V; Zhang Z; Kim SH; Mohyeldin A; Pavlyukov MS; Minata M; Valentim CL; Chhipa RR; Bhat KP; Dasgupta B; La Motta C; Kango-Singh M; Nakano I
    Cancer Res; 2016 Dec; 76(24):7219-7230. PubMed ID: 27569208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.
    Kim SH; Ezhilarasan R; Phillips E; Gallego-Perez D; Sparks A; Taylor D; Ladner K; Furuta T; Sabit H; Chhipa R; Cho JH; Mohyeldin A; Beck S; Kurozumi K; Kuroiwa T; Iwata R; Asai A; Kim J; Sulman EP; Cheng SY; Lee LJ; Nakada M; Guttridge D; DasGupta B; Goidts V; Bhat KP; Nakano I
    Cancer Cell; 2016 Feb; 29(2):201-13. PubMed ID: 26859459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation efficacy of 5-aminolevulinic acid-mediated photodynamic therapy on human glioma stem cells.
    Omura N; Nonoguchi N; Fujishiro T; Park Y; Ikeda N; Kajimoto Y; Hosomi R; Yagi R; Hiramatsu R; Furuse M; Kawabata S; Fukunaga K; Kuroiwa T; Nakano I; Wanibuchi M
    Photodiagnosis Photodyn Ther; 2023 Mar; 41():103119. PubMed ID: 36336324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular subtypes and differentiation programmes of glioma stem cells as determinants of extracellular vesicle profiles and endothelial cell-stimulating activities.
    Spinelli C; Montermini L; Meehan B; Brisson AR; Tan S; Choi D; Nakano I; Rak J
    J Extracell Vesicles; 2018; 7(1):1490144. PubMed ID: 30034643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages.
    Fan Y; Gao Z; Xu J; Wang H; Guo Q; Li B; Li M; Xu H; Qi Y; Zhao S; Qiu W; Pan Z; Wang Q; Xue H; Zhao R; Guo X; Li G
    Theranostics; 2023; 13(10):3310-3329. PubMed ID: 37351164
    [No Abstract]   [Full Text] [Related]  

  • 12. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting.
    Balasubramaniyan V; Vaillant B; Wang S; Gumin J; Butalid ME; Sai K; Mukheef F; Kim SH; Boddeke HW; Lang F; Aldape K; Sulman EP; Bhat KP; Colman H
    Oncotarget; 2015 Oct; 6(31):31007-17. PubMed ID: 26307681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinome-wide shRNA screen identifies the receptor tyrosine kinase AXL as a key regulator for mesenchymal glioblastoma stem-like cells.
    Cheng P; Phillips E; Kim SH; Taylor D; Hielscher T; Puccio L; Hjelmeland AB; Lichter P; Nakano I; Goidts V
    Stem Cell Reports; 2015 May; 4(5):899-913. PubMed ID: 25921812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specific inhibitor of ALDH1A3 regulates retinoic acid biosynthesis in glioma stem cells.
    Li J; Garavaglia S; Ye Z; Moretti A; Belyaeva OV; Beiser A; Ibrahim M; Wilk A; McClellan S; Klyuyeva AV; Goggans KR; Kedishvili NY; Salter EA; Wierzbicki A; Migaud ME; Mullett SJ; Yates NA; Camacho CJ; Rizzi M; Sobol RW
    Commun Biol; 2021 Dec; 4(1):1420. PubMed ID: 34934174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation.
    Bell JB; Eckerdt F; Dhruv HD; Finlay D; Peng S; Kim S; Kroczynska B; Beauchamp EM; Alley K; Clymer J; Goldman S; Cheng SY; James CD; Nakano I; Horbinski C; Mazar AP; Vuori K; Kumthekar P; Raizer J; Berens ME; Platanias LC
    Mol Cancer Res; 2018 Jan; 16(1):32-46. PubMed ID: 29042487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma.
    Bhat KP; Salazar KL; Balasubramaniyan V; Wani K; Heathcock L; Hollingsworth F; James JD; Gumin J; Diefes KL; Kim SH; Turski A; Azodi Y; Yang Y; Doucette T; Colman H; Sulman EP; Lang FF; Rao G; Copray S; Vaillant BD; Aldape KD
    Genes Dev; 2011 Dec; 25(24):2594-609. PubMed ID: 22190458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.
    Shao C; Sullivan JP; Girard L; Augustyn A; Yenerall P; Rodriguez-Canales J; Liu H; Behrens C; Shay JW; Wistuba II; Minna JD
    Clin Cancer Res; 2014 Aug; 20(15):4154-66. PubMed ID: 24907115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deubiquitinating ALDH1A3 key to maintaining the culprit of aggressive brain cancer.
    Wakimoto H
    J Clin Invest; 2019 Apr; 129(5):1833-1835. PubMed ID: 30958802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of MicroRNA via Macrophage-Derived Extracellular Vesicles Promotes Proneural-to-Mesenchymal Transition in Glioma Stem Cells.
    Zhang Z; Xu J; Chen Z; Wang H; Xue H; Yang C; Guo Q; Qi Y; Guo X; Qian M; Wang S; Qiu W; Gao X; Zhao R; Guo X; Li G
    Cancer Immunol Res; 2020 Jul; 8(7):966-981. PubMed ID: 32350000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.